The relationship between fatigue, psychological and immunological variables in acute infectious illness

Australian and New Zealand Journal of Psychiatry

Volumn 32, Issue 2, 1998, Pages 180-186

  Bennett, Barbara K ^a   Hickie, Ian B ^a   Vollmer Conna, Ute S ^a   Quigley, Bronwyn ^a   Brennan, Catherine M ^a   Wakefield, Denis ^a   Douglas, Michael P ^b   Hansen, Geoffrey R ^a   Tahmindjis, Alex J ^a   Lloyd, Andrew R ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Centre for Population Health   (Australia)

Author keywords

Cell mediated immunity; Depression; Fatigue; Viral illness

Indexed keywords

ADOLESCENT; ADULT; AGED; ALPHA VIRUS; ANXIETY; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; DELAYED HYPERSENSITIVITY; DEPRESSION; EPSTEIN BARR VIRUS; FATIGUE; FOLLOW UP; HUMAN; INFECTION; INTERVIEW; MALAISE; MALE; Q FEVER; QUESTIONNAIRE; SYMPTOM; TIME;

EID: 7144222748     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.3109/00048679809062727     Document Type: Article

References (33)

1. Hart B. Biological basis of the behaviour of sick animals. Neuroscience and Biobehavioural Reviews 1988; 12:123-137.
2. Hart B. Behavioural adaptations to pathogens and parasites: five strategies. Neuroscience and Biobehavioural Reviews 1990; 14:273-294.
3. Dinarello CA. Interleukin-1. Review of Infectious Diseases 1984; 6:51-95.
4. Dinarello CA. Interleukin-1 and the pathogenesis of the acute phase response. New England Journal of Medicine 1984; 311:1413-1418.
5. O'Garra A. Interleukins and the immune system 1, Lancet 1989; I.943-947.
6. Lloyd A, Hickie I, Peterson P. Chronic fatigue syndrome. In Richman DD, Whitley RJ, Hayden FG, eds. Clinical virology. New York: Churchill Livingstone, 1977:343-355.
7. Smith A, Tyrrell D, Coyle K, Higgins P. Effects of mterferon alpha on performance in man: a preliminary report Psychopharmacology 1988; 96:414-416.
8. Krueger JM, Walter J, Dinarello CA, Wolff SM, Chedid L. Sleep-promoting effects of endogenous pyrogen (interleukin-1). American Journal of Physiology 1984; 246:R994-R999
9. Smedley H, Katrak M, Sikora K, Wheeler T. Neurological effects of recombinant human interferon. British Medical Journal 1983; 286:262-264.
10. Smith AP, Tyrrell DAJ, Al-Nakib W et al. The effects of experimentally induced respiratory virus infections on performance. Psychological Medicine 1988; 18:65-71.
11. Vollmer-Conna U, Wakefield D, Lloyd A et al. Cognitive deficits in patients suffering from chronic fatigue syndrome, acute infective illness or depression. British Journal of Psychiatry 1997; 171:377-381.
12. !2. Schooley RT Epstein-Barr virus (infectious mononucleosis) In; Mandell GL, Douglas RG, Bennett JE, eds, Principles and practice of infectious diseases. 3rd ed. New York: Churchill Livingstone, 1995:1364-1377.
13. White PD, Thomas JM, Amess J, Grover SA, Kangro HO, Clare AW. The existence of a fatigue syndrome after glandular fever. Psychological Medicine 1995; 25:907-916.
14. White PD, Grover SA, Kangro HO, Thomas JM, Amess J, Clare AW. The validity and reliability of the fatigue syndrome that follows glandular fever. Psychological Medicine 1995; 25:917-924.
15. Fraser JRE. Epidemic polyarthritis and Ross River virus disease. Clinics in Rheumatic Diseases 1986; 12:369-388.
16. Curran M, Harvey B, Crerar S et al. Australia's notifiable diseases status 1996. Communicable Diseases Intelligence 1997: 21:281-307.
17. Seldon SM, Cameron AS, Changing epidemiology of Ross River virus disease in South Australia. Medical Journal of Australia 1996; 165:313-317.
18. National Centre for Diseases Unit, Department of Health and Family Services. Communicable diseases surveillance. Communicable Diseases Intelligence 1997; 21:323-331.
19. Marmion BOP, Shannon M, Maddocks I, Storm P, Penttila I. Protracted debility and fatigue after acute Q fever [letter]. Lancet 1996; 347:977-978.
20. Hickie I, Lloyd A, Wakefield D, Ricci C. Is there a postinfection fatigue syndrome? Australian Family-Physician 1996; 1847-1852.
21. Composite International Diagnostic Interview. CIDI-Auto version 1.1 [computer program] Sydney. WHO CIDI Training and Reference Centre, 1993.
22. Hickie I, Lloyd A, Hadzi-Pavlovic D, Parker G, Bird K, Wakefield D. Can the chronic fatigue syndrome be defined by distinct clinical features? Psychological Medicine 1995; 25:925-935.
23. Hickie IB, Hooker AW, Hadzi-Pavlovic D, Bennett BK, Wilson AW, Lloyd AR. Fatigue in selected primary care settings: sociodemographic and psychiatric correlates. Medical Journal of Australia 1996; 164:585-588.
24. McNair DM, Lorr M, Droppleman LE. Manual for the Profile of Mood States. San Diego: San Diego Educational and Industrial Testing Service, 1971.
25. Goldberg D, Williams P. A user's guide to the General Health Questionnaire. Berkshire: NFER-Nelson Publishing. 1988.
26. Kniker WT, Andersen CT, Roumiantzeff M. The multi-test system: a standardized approach to evaluation of delayed hyper-sensitivity and cell-mediated immunity. Annals of Allergy 1979; 43:73-79.
27. Kniker WT, Anderson CT, McBryde JL, Roumiantzeff M, Lesourd B. Multitest CMI for standardized measurement of delayed cutaneous hypersensitivity and cell-mediated immunity. Normal values and proposed scoring system for healthy adults in the USA. Annals of Anergy 1984; 52:75-81.
28. Lloyd A, Hickie I, Hickie C, Wakefield D, Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression. Clinical and Experimental Immunology 1992; 87:76-79.
29. Hickie I, Hickie C, Lloyd A, Silove D, Wakefield D. Impaired in vivo immune responses in patients with melancholia. British Journal of Psychiatry 1993; 162:651-657.
30. Hickie I, Hickie C, Silove D, Wakefield D, Lloyd A. Delayed type hypersensitivity skin testing: normal values in an Australian population. International Journal of Immunopharmacology 1995; 17(Suppl.):629-634.
31. Haider S, Coutinho M de L, Emond RTD. Tuberculin anergy and infectious mononucleosis. Lancet 1973; 2.74.
32. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A, and the International Chronic Fatigue Syndrome Study Group. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Annals of Internal Medicine 1994; 121:953-959.
33. Hickie I, Lloyd AR, Wakefield D. Chronic fatigue syndrome: current perspectives on evaluation and management. Medical Journal of Australia 1995; 163:314-318.